Ardent Health, Inc. (NYSE:ARDT) Stock Has Consensus Price Target of $12.79

Shares of Ardent Health, Inc. (NYSE:ARDT) have been assigned an average rating of “Hold” from the fifteen brokerages that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and seven have assigned a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $12.79.

Several equities research analysts have issued reports on ARDT shares. Truist Financial boosted their price target on shares of Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Royal Bank Of Canada raised their price objective on shares of Ardent Health from $12.00 to $13.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $13.00 price objective on shares of Ardent Health in a report on Thursday, August 6th. BMO Capital Markets began coverage on shares of Ardent Health in a research report on Tuesday, September 22nd. They set a “market perform” rating and a $11.00 target price on the stock. Finally, Leerink Partners reissued an “outperform” rating and issued a $14.00 target price on shares of Ardent Health in a research note on Friday, September 18th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Allworth Financial LP bought a new stake in shares of Ardent Health in the 2nd quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd lifted its position in shares of Ardent Health by 2,036.6% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 4,786 shares of the company’s stock worth $42,000 after buying an additional 4,562 shares during the period. Integrated Wealth Concepts LLC bought a new position in shares of Ardent Health during the 2nd quarter worth approximately $57,000. Abel Hall LLC acquired a new stake in Ardent Health in the 1st quarter valued at $87,000. Finally, Canada Pension Plan Investment Board acquired a new stake in Ardent Health in the 2nd quarter valued at $118,000.

Ardent Health Price Performance

Shares of NYSE:ARDT opened at $12.28 on Wednesday. Ardent Health has a 1-year low of $7.71 and a 1-year high of $15.48. The firm has a market capitalization of $1.73 billion, a PE ratio of 22.33, a PEG ratio of 3.50 and a beta of 0.72. The business’s 50 day moving average is $11.04 and its 200-day moving average is $10.29. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61.

Ardent Health (NYSE:ARDT) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). The firm had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Sell-side analysts predict that Ardent Health will post 0.96 earnings per share for the current year.

About Ardent Health

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.